MindMaze is a Non-Invasive Clinical EEG company founded in 2012 and based in Lausanne, Switzerland. It has raised $233.5M in total funding, most recently a Growth in 2021 at a $1.5B valuation.
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| Oct 7, 2021 | Growth | $125M | $1.5B | AlbaCore Capital Group |
| Feb 17, 2016 | Series A | $100M | $1B |
| Hinduja Group |
No articles ingested yet for MindMaze. Once the hourly news pipeline is live, every article the classifier tags as mentioning this company appears here with its one-line AI summary and sentiment.
FDA-cleared and CE-marked virtual reality rehabilitation system for stroke and neurological patients. Delivers gamified motor and cognitive exercises on a tablet-based platform, using real-time motion capture to guide and assess patient movement. Deployed in hospitals and outpatient rehabilitation centers globally, with outcomes tracking and clinician dashboards.
Clinic-based immersive VR rehabilitation system combining large-format display environments with EEG-based neurofeedback to accelerate motor recovery in stroke patients. FDA-cleared and CE-marked, targeting upper-limb rehabilitation for patients in acute and subacute post-stroke phases.
2 patents on file, but none with both an extractable figure and an abstract on Google Patents yet.
We don't have a live feed for this company's ATS. Their careers page has every open role.
View all careers ↗